Skip to main content
. 2024 Oct 15;16(10):6688–6698. doi: 10.21037/jtd-24-952

Table 3. Association of aspirin use with primary outcomes using logistic regression analysis.

Outcomes Model 1 Model 2 Model 3
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
In-hospital death
   Aspirin use 0.500 (0.403, 0.620) <0.001 0.605 (0.493, 0.742) <0.001 0.574 (0.456, 0.721) <0.001
28-day mortality
   Aspirin use 0.470 (0.386, 0.573) <0.001 0.563 (0.467, 0.677) <0.001 0.539 (0.437, 0.665) <0.001

Model 1: age, gender, renal disease, coronary artery disease, diabetes, and hypertension were adjusted; model 2: heart rate, DBP, SBP, SpO2, glucose, hematocrit, Pt, mechanical ventilation use, and CRRT were adjusted; model 3, all covariates adjusted including age, gender, heart rate, DBP, SpO2, glucose, hematocrit, Pt, renal disease, coronary artery disease, diabetes, hypertension, mechanical ventilation use, and CRRT. OR, odds ratio; CI, confidence interval; DBP, diastolic blood pressure; SBP, systolic blood pressure; SpO2, oxygen saturation; CRRT, continuous renal replacement therapy; Pt, prothrombin time.